Functional link of BRCA1 and ataxia telangiectasia gene product in DNA damage response - PubMed (original) (raw)
. 2000 Jul 13;406(6792):210-5.
doi: 10.1038/35018134.
Affiliations
- PMID: 10910365
- DOI: 10.1038/35018134
Functional link of BRCA1 and ataxia telangiectasia gene product in DNA damage response
S Li et al. Nature. 2000.
Abstract
BRCA1 encodes a familial breast cancer suppressor that has a critical role in cellular responses to DNA damage. Mouse cells deficient for Brca1 show genetic instability, defective G2-M checkpoint control and reduced homologous recombination. BRCA1 also directly interacts with proteins of the DNA repair machinery and regulates expression of both the p21 and GADD45 genes. However, it remains unclear how DNA damage signals are transmitted to modulate the repair function of BRCA1. Here we show that the BRCA1-associated protein CtIP becomes hyperphosphorylated and dissociated from BRCA1 upon ionizing radiation. This phosphorylation event requires the protein kinase (ATM) that is mutated in the disease ataxia telangiectasia. ATM phosphorylates CtIP at serine residues 664 and 745, and mutation of these sites to alanine abrogates the dissociation of BRCA1 from CtIP, resulting in persistent repression of BRCA1-dependent induction of GADD45 upon ionizing radiation. We conclude that ATM, by phosphorylating CtIP upon ionizing radiation, may modulate BRCA1-mediated regulation of the DNA damage-response GADD45 gene, thus providing a potential link between ATM deficiency and breast cancer.
Similar articles
- Differing effects of breast cancer 1, early onset (BRCA1) and ataxia-telangiectasia mutated (ATM) mutations on cellular responses to ionizing radiation.
Mamon HJ, Dahlberg W, Azzam EI, Nagasawa H, Muto MG, Little JB. Mamon HJ, et al. Int J Radiat Biol. 2003 Oct;79(10):817-29. doi: 10.1080/09553000310001610952. Int J Radiat Biol. 2003. PMID: 14630541 - Role for ATM in DNA damage-induced phosphorylation of BRCA1.
Gatei M, Scott SP, Filippovitch I, Soronika N, Lavin MF, Weber B, Khanna KK. Gatei M, et al. Cancer Res. 2000 Jun 15;60(12):3299-304. Cancer Res. 2000. PMID: 10866324 - Effect of DNA damage on a BRCA1 complex.
Wu-Baer F, Baer R. Wu-Baer F, et al. Nature. 2001 Nov 1;414(6859):36. doi: 10.1038/35102118. Nature. 2001. PMID: 11689934 - ATM: the protein encoded by the gene mutated in the radiosensitive syndrome ataxia-telangiectasia.
Lavin MF, Khanna KK. Lavin MF, et al. Int J Radiat Biol. 1999 Oct;75(10):1201-14. doi: 10.1080/095530099139359. Int J Radiat Biol. 1999. PMID: 10549596 Review. - Ataxia-telangiectasia mutated kinase (ATM) as a central regulator of radiation-induced DNA damage response.
Tichý A, Vávrová J, Pejchal J, Rezácová M. Tichý A, et al. Acta Medica (Hradec Kralove). 2010;53(1):13-7. doi: 10.14712/18059694.2016.57. Acta Medica (Hradec Kralove). 2010. PMID: 20608227 Review.
Cited by
- miR-4796 enhances the sensitivity of breast cancer cells to ionising radiation by impairing the DNA repair pathway.
Jiang T, Chen J, Wang Z, Wang X, Ma J, Zhao F, Huang C, Chen Y. Jiang T, et al. Breast Cancer. 2023 Sep;30(5):691-702. doi: 10.1007/s12282-023-01482-1. Epub 2023 Jul 17. Breast Cancer. 2023. PMID: 37460775 - Mechanisms of PARP1 inhibitor resistance and their implications for cancer treatment.
Jackson LM, Moldovan GL. Jackson LM, et al. NAR Cancer. 2022 Dec 22;4(4):zcac042. doi: 10.1093/narcan/zcac042. eCollection 2022 Dec. NAR Cancer. 2022. PMID: 36568963 Free PMC article. - Interplays of glucose metabolism and KRAS mutation in pancreatic ductal adenocarcinoma.
Liu YH, Hu CM, Hsu YS, Lee WH. Liu YH, et al. Cell Death Dis. 2022 Sep 24;13(9):817. doi: 10.1038/s41419-022-05259-w. Cell Death Dis. 2022. PMID: 36151074 Free PMC article. Review. - Epigenetic inactivation of DNA repair genes as promising prognostic and predictive biomarkers in urothelial bladder carcinoma patients.
Mohanad M, Yousef HF, Bahnassy AA. Mohanad M, et al. Mol Genet Genomics. 2022 Nov;297(6):1671-1687. doi: 10.1007/s00438-022-01950-x. Epub 2022 Sep 8. Mol Genet Genomics. 2022. PMID: 36076047 Free PMC article. - Comprehensive Analysis of the Expression and Prognostic Value of LMAN2 in HER2+ Breast Cancer.
Zhang D, Ye L, Hu S, Zhu Q, Li C, Zhu C. Zhang D, et al. J Immunol Res. 2022 Jun 6;2022:7623654. doi: 10.1155/2022/7623654. eCollection 2022. J Immunol Res. 2022. PMID: 35707004 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Molecular Biology Databases
Research Materials
Miscellaneous